Galera Therapeutics (GRTX)
Galera Therapeutics, Inc., a biopharmaceutical company, focuses on the development of a portfolio of small molecule dismutase (SOD) mimetics to improve radiothe...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 0.0880
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- 0.1500
- Volume Ratio
- 0.00
- Turnover Ratio
- --
News
- PUBT · Aug 4 at 05:13 AM
Galera plans Form 15 filing to end SEC registration, suspend Exchange Act reporting after merger
- Tip Ranks · Jul 13 at 06:22 PM
Galera Therapeutics Announces Material Changes to Security Holder Rights
- Tip Ranks · Jul 7 at 08:30 AM
Galera Therapeutics Announces Major Reverse Stock Split
- PUBT · Jul 7 at 07:50 AM
Galera Therapeutics announces 1-for-200 reverse stock split effective July 12
- TradingView · Jun 11 at 04:36 PM
Parvinder Singh Hyare Backs Obsidian Deal at Galera Therapeutics with 6.65% Stake
- Tip Ranks · May 15 at 06:02 AM
Galera Therapeutics Expands Share Authorization, Enhances Stockholder Rights
